Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 70 recruiting now full pipeline #15 of 28,963 conditions

Asthma: full-pipeline trial registry

70 of 378 indexed Asthma trials are currently recruiting.

Corpus placement: #15 of 28,963 conditions by registered trial count.

378 US clinical trials · 70 currently recruiting · #15 of 28,963 conditions by registered trial count

Asthma: 378 US clinical trials tracked, 70 recruiting.

Asthma is the subject of 378 registered US clinical trials on ClinicalTrials.gov, 70 of them currently open to new participants. 89 are in Phase 3-4 (later-stage) and 108 in Phase 1-2 (earlier-stage). The most active sponsor is GlaxoSmithKline, running 24 of these trials.

Open enrollment snapshot

Asthma has 378 registered US clinical trials, 70 of them open to new participants right now, about 19% of the total.

70
recruiting participants now
19%
of trials open to enrollment
89
in Phase 3-4 (later-stage)
24
top sponsor: GlaxoSmithKline

Corpus placement: #15 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.

Key findings

What ClinicalTrials.gov does not surface for Asthma on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Asthma is recruiting below its size-band peers.

    70 of 378 indexed trials (18.5%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Asthma trials is spread across many organizations.

    GlaxoSmithKline accounts for 24 of 378 trials (6.3%). 161 distinct sponsors appear on at least one study for this condition label.

  3. Typical Asthma enrolment sits around 144 participants.

    Median target enrolment is 144 among the 375 trials that report a genuine target (sentinel values excluded). 160 of those (42.7%) plan for fewer than 100 participants.

  4. Asthma research is mostly interventional.

    298 interventional and 80 observational studies make up this index (78.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 127Phase 281Phase 351Phase 438

Open and recent trials

378 total, page 8 of 8

COMPLETED 18 participants

Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)

AstraZeneca

NCT03373045

COMPLETED Phase 2 18 participants

Biomarkers of Irritant-Induced and Allergic Asthma

NYU Langone Health

NCT02740543

COMPLETED NA 17 participants

E-cigarettes for Harm Reduction in Adults With Asthma

Brown University

NCT05278065

COMPLETED Phase 2 16 participants

Study in Patients With Asthma

Dey

NCT00215397

COMPLETED Phase 4 16 participants

The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma

University of Florida

NCT00133042

COMPLETED NA 16 participants

Effect of a Component of Fish Oil on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma

Indiana University

NCT01200446

COMPLETED NA 16 participants

Feasibility of Ripple Health Smart Pill Caps in Clinical Settings

Manan Shukla

NCT05192928

COMPLETED 15 participants

Roflumilast In-Vitro Basophil Release

Creighton University

NCT00613587

COMPLETED NA 15 participants

Telehealth Enhanced Asthma Management

Arkansas Children's Hospital Research Institute

NCT03414177

COMPLETED Phase 2 15 participants

PF-04191834 Single Dose Bronchodilatory Study In Asthma.

Pfizer

NCT00723021

COMPLETED Phase 4 15 participants

Effects of Interleukin (IL)- 4R-alpha Inhibition on Respiratory Microbiome and Immunologic Correlates in Severe Asthma

University of Michigan

NCT05036733

COMPLETED Phase 2 14 participants

Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique

Teva Branded Pharmaceutical Products R&D

NCT00054964

COMPLETED NA 12 participants

Respiratory Disorders Non-invasive Monitoring of Work of Breathing in Outpatients

Stanford University

NCT04003415

COMPLETED NA 12 participants

Evaluation of Traditional Paper Symptom Diary vs. the VOCEL Mobile Diary

Allergy & Asthma Medical Group & Research Center

NCT00367263

COMPLETED NA 12 participants

Electronic Health Record (EHR) Decision Support to Improve Outpatient Asthma Care

Children's Hospital of Philadelphia

NCT00918944

COMPLETED NA 12 participants

Using Mobile Phones to Improve Adherence to Inhaled Steroids

Rush University Medical Center

NCT01710059

COMPLETED Phase 4 12 participants

Impact of Anti-static Chamber/Mask

University of Florida

NCT00307970

COMPLETED Phase 1 11 participants

A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis

Ansun Biopharma

NCT01113034

COMPLETED NA 7 participants

Imaging Study of the Lungs During an Allergic Asthma Attack

Massachusetts General Hospital

NCT01547286

COMPLETED NA 7 participants

Rural Home Hospital: Proof of Concept

Brigham and Women's Hospital

NCT04531280

COMPLETED NA 7 participants

Evaluation of Negative Inspiratory Flow in Children With Acute Asthma

Winthrop University Hospital

NCT05762978

COMPLETED Phase 4 6 participants

Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)

University of California, Davis

NCT00367016

COMPLETED Phase 2 6 participants

The Effects of NOx and Conjugated Linoleic Acid on Asthmatics

Gladwin, Mark, MD

NCT02433977

COMPLETED 6 participants

Menstrual Differences in Airway Inflammation in Asthma

The University of Texas Medical Branch, Galveston

NCT00584441

COMPLETED NA 1 participants

Stimulation of the Cervical Sympathetic Ganglion for Treatment of Asthma

Jonathan Parsons

NCT01724307

COMPLETED

Outcomes From an Asthma Disease Management Program

Children's Mercy Hospital Kansas City

NCT00137722

COMPLETED Phase 2

Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids

Hoffmann-La Roche

NCT00048009

COMPLETED Phase 2

A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma

Astellas Pharma

NCT00116103

← Previous Page 8 of 8

Phase Distribution

PhaseTrial count
Phase 1 27
Phase 2 81
Phase 3 51
Phase 4 38

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What is open for Asthma right now

70 recruiting of 378 indexed (19% open).

Phase mix: 89 late (III/IV) vs 108 early (I/II) (balanced across stages).

Top sponsor: GlaxoSmithKline (24 trials), 9 others listed. 28 shown below, recruiting first. #15 of 28,963 conditions by registered trial count.

How open-enrollment share is computed

Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.

Frequently Asked Questions

How many clinical trials are there for Asthma?

PlainTrial tracks 378 US clinical trials for Asthma, of which 70 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Asthma?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.